Proactive Investors - Run By Investors For Investors

Collagen Solutions assesses last patient in ChondroMimetic trial

Jamal Rushdy, chief executive of Collagen Solutions PLC (LON:COS) tells Proactive they're now putting together the results of a retrospective, eight-year study of its ‘scaffold’ product that helps fix cartilage defects in the knee.

The 15 patients whose results are being analysed took part in a 2009/10 trial.

 
Meet Alliance Pharma plc, IXICO PLC, Benchmark Holdings PLC, Clinigen Group PLC and Shield Therapeutics PLC at our event, London , 24 January 2019. Register here »
View full COS profile View Profile

Collagen Solutions PLC Timeline

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use